|Articles|November 19, 2015
Michael J. Mauro Discusses the Diagnosis of CML
Author(s)Michael J. Mauro
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Michael J. Mauro, leader, Myeloproliferative Neoplasms Program, Memorial Sloan Kettering Cancer Center, discusses the diagnosis of chronic myeloid leukemia (CML).
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on CURE
1
Why Is Lung Health Key to Survivorship After Cancer Treatment?
2
U.S. Soccer Legend Kasey Keller Reveals Lymphoma Journey
3
New Combination Treatment Approach Studied in Pancreatic Cancer
4
The Power of Personalized Care in Breast Cancer Treatment
5